Celiac Disease in Children with Functional Constipation: A School-Based Multicity Study

Amanda C Fifi1, Carlos Velasco-Benitez2, Miguel Saps1

  • 1Department of Pediatrics, University of Miami, Miami, FL.

Insights

This study found no increased prevalence of celiac disease in Colombian schoolchildren with functional constipation compared to healthy peers. Routine screening for celiac disease in these children is not recommended.

Area of Science:

  • Pediatric Gastroenterology
  • Gastroenterology
  • Celiac Disease Research

Background:

  • Functional constipation is a common pediatric gastrointestinal disorder.
  • Celiac disease is an autoimmune disorder triggered by gluten consumption.
  • The relationship between functional constipation and celiac disease in children requires further investigation.

Purpose of the Study:

  • To determine if children with functional constipation have a higher prevalence of celiac disease.
  • To assess the need for routine celiac disease screening in children presenting with functional constipation.

Main Methods:

  • A cohort of 1809 schoolchildren in Colombia were screened for functional gastrointestinal disorders (FGIDs).
  • Children with functional constipation were matched with healthy controls.
  • Celiac disease screening involved tissue transglutaminase (tTG)-Immunoglobulin A (IgA) testing, HLA genotyping, and duodenal biopsies for Marsh criteria classification.

Main Results:

  • The overall prevalence of celiac disease in the cohort was 0.6%.
  • One child (0.5%) with functional constipation and three controls (0.7%) were diagnosed with celiac disease.
  • There was no statistically significant difference in celiac disease prevalence between the groups (P = .743).

Conclusions:

  • The prevalence of celiac disease in schoolchildren with functional constipation is similar to that in healthy children.
  • Routine screening for celiac disease in children with functional constipation is not indicated based on these findings.
Abstract

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
631
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
542
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
675
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
563
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
916
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
560